Form 4: Stryker VP Granted 8,980 Stock Options
Insider Transaction Report
Stryker's VP and Chief Legal Officer, Robert S Fletcher, was granted 8,980 employee stock options with an exercise price of $360.82 per share.
Summary
- Robert S Fletcher, VP, Chief Legal Officer of Stryker Corporation (SYK), was granted 8,980 employee stock options.
- The options were granted on February 4, 2026, with an exercise price of $360.82 per share.
- These options are exercisable as to 20% on each of the first five anniversaries of the grant date.
- The options expire on February 3, 2036.
- The grant was made pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices that align management incentives with shareholder interests, though it is not a significant market-moving announcement.
Positives
- The grant of 8,980 employee stock options aligns the interests of the VP, Chief Legal Officer, Robert S Fletcher, with those of shareholders, incentivizing long-term company performance.
- The options are part of the Stryker Corporation 2011 Long-Term Incentive Plan, indicating a structured approach to executive compensation.
Future Outlook
The employee stock options will become exercisable in annual increments of 20% over the next five years, starting from the first anniversary of the grant date.
Industry Context
StockSavvy.ai notes that the grant of stock options to key executives like the Chief Legal Officer is a standard practice in the medical technology and broader corporate sectors. This type of compensation is designed to align executive incentives with long-term shareholder value creation, a common strategy among publicly traded companies to retain talent and encourage performance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Authorization | Robert S. Fletcher granted a Power of Attorney to Austin Y. Ke, Jessica R. Kennedy, Jessica M. Herron, Garrett Packer, and Stephanie M. Swan to prepare, execute, and file SEC forms, schedules, and other documents on his behalf. | 09/02/2025 | Streamlines the process for the reporting person to comply with SEC filing requirements under Sections 13 and 16 of the Exchange Act, ensuring timely and accurate disclosures. |
Stakeholder Impact
- Shareholders: The grant of stock options aims to align the interests of the Chief Legal Officer with shareholders, potentially leading to improved long-term company performance and value creation.
- Employees (specifically Robert S Fletcher): This grant represents a significant component of his compensation, providing a direct financial incentive tied to the company's stock performance.
Next Steps
- The options will vest annually at 20% on each of the first five anniversaries of the grant date (February 4, 2026).
Key Dates
| Date | Description |
|---|---|
| 09/02/2025 | Date Robert S. Fletcher executed the Power of Attorney for SEC filings. |
| 02/04/2026 | Date of employee stock option grant to Robert S Fletcher. |
| 02/06/2026 | Date the Form 4 was signed by attorney-in-fact. |
| 02/03/2036 | Expiration date of the granted employee stock options. |
Recommendation
holdThis Form 4 filing details a routine executive compensation grant and does not contain information that would typically alter an investment thesis or warrant a change in stock recommendation for a seasoned investor or institution.
Keywords
Stryker, SYK, Stock Option, Executive Compensation, Insider Transaction, Form 4, Robert S Fletcher
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.